AmpliTech 5G Division Releases New Band 50 Open RAN Radios Proof Of Concept Phase Complete – Production Shipments To Start December 2025AmpliTech launches new Band 50 (n50) 5G Open RAN radios, engineered for long-range FWA coverage with low power consumption and full O-RAN 7.2x compatibility.Successful field trials on a major LOI project, enabling the company to proceed to production and initial shipments starting December 2025.Revenue outlook increases from $78M to over $100M, supported by multi-year depl ...

BLAQclouds, Inc. Provides Update on OTC Markets Yield Sign and Filing Corrections Key TakeawaysYield Sign Trigger Resolved — Blaqclouds corrected a share-count mismatch in its quarterly report and submitted an amended filing now under OTC review.Transition Beyond Legacy Management — This is the final filing containing any data from previous leadership; all future disclosures reflect the current team’s structure and technology.Strengthened Transparency & Q4 Profit Push — Despite prior management’s issuance ...

Core Insights - Flyte, Inc. is expanding its fleet of Cirrus Vision Jets as part of its growth strategy for FY2026, aiming to operate ten Vision Jets and three Pilatus aircraft [2][6] - The expansion is supported by a strengthened balance sheet, reduced liabilities, and improved operational efficiency, attracting interest from strategic partners and investors [5][6] - Recent federal programs providing passive-income advantages for aviation-asset participation have increased investor engagement in Flyte's fleet expansion initiatives [5][7] Fleet Strategy - Flyte's fleet strategy focuses on efficient, mission-versatile aircraft that can meet both passenger and medical-logistics demands [4] - The Cirrus Vision Jet is noted for its low operating costs, advanced safety systems, and suitability for short- and mid-range missions [4] - The planned Pilatus aircraft will enhance the Vision Jet platform by offering greater payload and multi-mission capabilities for extended routes [4] Financial Position - The acquisition of additional Cirrus Vision Jets reflects Creatd's strengthened financial position and ongoing year-over-year revenue growth [6] - The company is actively pursuing further assets, including additional Vision Jets from the Verijet, Inc. bankruptcy [6]

Core Insights - BlockQuarry Corp. has achieved significant industry recognition for its BLQCBuster™ following its debut at the Mining Disrupt Conference, indicating strong market potential for American-made mining hardware [2][4][6] Group 1: Product and Technology - The BLQCBuster™ features innovative modular architecture and advanced rack-mount capabilities, designed for scalability and operational efficiency, addressing supply chain vulnerabilities [3][10] - The first-generation model (Gen-1) has successfully completed a 60-day validation test, while the second-generation model (Gen-2) is nearing production readiness with only minor modifications needed [5][6][9] Group 2: Market Reception and Demand - The response at the Mining Disrupt Conference was overwhelmingly positive, with industry leaders recognizing the competitive advantages of the BLQCBuster™, leading to increased pre-order interest from established operators [4][6][7] - The company is preparing for structured commercialization and plans to showcase production units at the Mining Disrupt 2026 event, indicating a proactive approach to market entry [6][9] Group 3: Strategic Initiatives - BlockQuarry's decision to sponsor a networking event at Mining Disrupt attracted significant industry engagement, showcasing the BLQCBuster's technical capabilities and differentiating it from existing market solutions [7][8] - The company is developing a qualified prospect pipeline and establishing a pre-order framework to facilitate efficient market entry once final testing is completed [8][9]

Core Insights - BLAQclouds, Inc. has announced a strategic alignment with Metavesco, Inc. following a two-day leadership summit focused on Web3 infrastructure and decentralized trading models [4][5][6] Group 1: Strategic Collaboration - The two companies collaborated on key areas including tokenization of public markets and liquidity engineering for OTC markets [5][6] - BLAQclouds acquired a strategic early position in the OTCfi SOL token, indicating confidence in the transformation of public markets through blockchain technology [6][8] Group 2: OTCfi's Mission and Roadmap - OTCfi aims to revolutionize OTC market dynamics using the Solana blockchain, with a roadmap that includes systematic onboarding for microcap issuers and tokenized liquidity pools [6][7] - The leadership team of BLAQclouds described OTCfi's roadmap as a bold vision for enhancing microcap liquidity in the Web3 era [8] Group 3: Community Engagement - A recorded Q&A session with Metavesco CEO Ryan Schadel was held for BLAQclouds' VIP community, focusing on OTCfi's mission and technology [9][10] - Access to the recorded session requires identity verification through BLAQclouds' IncognitoKYC platform [10] Group 4: Future Collaboration Opportunities - Both organizations are exploring further collaborative efforts, which may include joint development of tokenization and compliance tools, as well as pilot programs across their ecosystems [14]

Core Insights - AmpliTech Group, Inc. reported a record Q3 2025 with significant revenue growth and improved financial metrics, marking a pivotal moment towards profitability [3][7][10] Financial Performance - Q3 2025 revenue surged 115% to $6.09 million, compared to $2.83 million in Q3 2024 [8] - Gross profit more than doubled to $2.96 million, achieving a gross margin of 48.6%, up from 47.5% in the prior year [8] - Net loss narrowed significantly to $188,000 or $0.01 per share, compared to a net loss of $1.19 million or $0.12 per share in Q3 2024 [8] - Year-to-date revenue for the first nine months of 2025 reached $20.7 million, a 171% increase from $7.7 million in the same period last year [8] Operational Highlights - The company raised its full-year revenue forecast for FY2025 to $25 million, representing a 160% year-over-year increase [7][13] - FY2026 revenue guidance is set at $50 million, with expectations of positive cash flow [7][13] - Continued investment in R&D increased by 60%, supporting new product development in advanced technologies [8] Strategic Positioning - AmpliTech is advancing its 5G ORAN and satellite technologies, positioning itself as a leader in private network solutions [7][10] - The integration of ORAN IP portfolio enhances AmpliTech's capabilities as a vertically integrated supplier for next-generation open-RAN 5G radios [8] Financial Strength - As of September 30, 2025, the company reported $11.9 million in cash and receivables with zero long-term debt [8] - Working capital stood at $14.0 million, indicating a strong balance sheet [8] Future Outlook - The company anticipates double-digit gross margins in Q4 2025 and FY2026 as production costs normalize [13] - Projected profitability is expected to be achieved in FY2026, assuming the continuation of current order pace and margin recovery [13]

Core Insights - AtlasClear Holdings reported significant financial improvements in Q1 FY2026, achieving positive stockholders' equity and securing $20 million in financing, which alleviated previous liquidity concerns [4][5][7] - The company is experiencing operational growth across its business lines, particularly in correspondent clearing and stock loan platforms, with expectations for continued revenue growth in 2026 [4][6] Financial Highlights - Revenue for the quarter reached $4.25 million, a 52% increase year-over-year from $2.8 million in Q1 FY2025 [7] - Operating loss improved to $(877,000) from $(941,000) in the prior-year period, while net loss was $(440,000), a significant change from net income of $10.7 million in Q1 FY2025 [7] - Total assets increased to $73.6 million, up 21% from $60.9 million at June 30, 2025, and stockholders' equity was positive at $6.86 million compared to a deficit of $(6.8) million [7] Operational and Corporate Highlights - The company signed its third correspondent clearing customer, which is expected to contribute to revenues in 2026 [6][7] - A partnership with LocBox is expanding to include digital asset loans and management platforms in fiscal 2026 [7] - The management team has been strengthened with the appointment of Sandip Patel as CFO/GC and Steven Carlson as Independent Director [7]

Core Insights - BioStem Technologies reported a significant decrease in net revenue for Q3 2025, totaling $10.5 million, which is a 43% decline compared to Q3 2024, primarily due to lower volume in the wound care portfolio amid reimbursement uncertainties and increased competition [7][9] - The company remains focused on strategic initiatives, including advancing clinical programs, expanding payer access, and evaluating potential acquisitions to diversify its product offerings [5][9] Financial Highlights - Net revenue for Q3 2025 was $10.5 million, down from $18.4 million in Q3 2024, reflecting a 43% decrease [7] - Gross profit was $9.3 million, representing 88.5% of net revenue, compared to $14.2 million or 77.0% of net revenue in Q3 2024, indicating a shift towards products without licensing fees [7] - Operating expenses increased to $7.8 million from $4.9 million in Q3 2024, driven by higher clinical trial activities and infrastructure investments [8] - GAAP net income was $0.8 million or $0.05 per share, down from $6.8 million or $0.42 per share in Q3 2024 [8] - Adjusted EBITDA for the quarter was $2.7 million, a decline from $10.4 million in Q3 2024, reflecting lower revenue and higher operating expenses [8] Business Developments - BioStem achieved a 40% growth in product volume quarter-over-quarter [9] - The company published positive results from the BioREtain® trial in the International Journal of Tissue Repair and completed FDA reinspection with no observations [9] - BioStem secured land for a new headquarters in Boca Raton and established a partnership with a Service-Disabled Veteran-Owned Small Business to enter the VA market [9] - The company reported restated financials in accordance with US GAAP, reflecting adjustments to the accounting treatment for bona fide services fees paid to its commercial partner [9][10] Cash Position - As of September 30, 2025, cash and cash equivalents totaled $27.2 million, providing a solid financial foundation for future operations [10]

Core Insights - BioStem Technologies, Inc. has filed restated interim financial statements for Q1 2024 through Q2 2025 and annual financial statements for 2023 and 2024, aligning with US GAAP revenue recognition standards [3][12]. Financial Restatement - The restatement is a significant milestone for the company, resulting from a comprehensive review of US GAAP revenue recognition guidance, particularly regarding the distribution agreement with Venture Medical [4][12]. - Bona fide services fees previously recorded as Sales and Marketing expenses will now be classified as contra revenue, reducing gross revenue but not impacting EBITDA, net income, or cash flow [5][12]. - The restated financials will affect percentage-based metrics such as gross margin and EBITDA margin due to the change in revenue reporting [5]. Balance Sheet Adjustments - Amounts owed to Venture Medical related to bona fide services fees will now be netted against Accounts Receivable, effectively offsetting the liabilities between the two companies [6]. Business Outlook - The company maintains that the underlying strength of its business remains unchanged, continuing to deliver clinically validated wound care products [7]. - The independent audit led by KPMG is expected to be completed by the end of Q1 2026, which will support the company's plans to uplist and enhance investor transparency [8][12].

Core Insights - Creatd, Inc. has engaged Dawson James Securities, Inc. as its financial advisor and Lucosky Brookman LLP as legal counsel to facilitate its uplisting strategy to a national securities exchange [4][5] - The company aims to enhance its capital markets strategy, increase institutional visibility, and improve shareholder value in line with national exchange listing standards [5][7] - CEO Jeremy Frommer will provide updates on the uplisting process during the upcoming Investor Conference on November 17, 2025 [5][7] Engagement of Advisors - Creatd has retained Dawson James Securities as financial advisor and Lucosky Brookman LLP as legal counsel to execute its uplisting plan [7] - This engagement is seen as a significant step in the company's efforts to prepare for a national exchange listing [5][7] Commitment to Growth - The company's actions are focused on strengthening its readiness for national exchange listing, which is expected to boost institutional visibility and shareholder value [5][7] - The strategic initiative reflects Creatd's commitment to long-term growth and capital market engagement [5][6] Upcoming Events - An Investor Conference is scheduled for November 17, 2025, where updates regarding the uplisting process will be shared by the CEO [5][7]